Celltrion has obtained the Food and Drug Administration’s clearance for a new presentation of Steqeyma (ustekinumab-stba), a biosimilar to Stelara (ustekinumab), in a 45mg/0.5ml solution in a ...
In an alarming escalation of his administration’s vaccine crackdown, President Donald Trump’s Food and Drug Administration is planning a presentation linking COVID-19 shots to children’s deaths, ...
The U.S. Food and Drug Administration has approved GSK's prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted) for the prevention of shingles (herpes zoster). The ...
REYKJAVIK, Iceland & PARSIPPANY, N.J., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical ...
GSK has received the Food and Drug Administration’s approval for a prefilled syringe presentation of Shingrix (GSK’s Recombinant Zoster Vaccine or RZV) for the prevention of shingles (herpes zoster).
Strategic Priorities and the Future of Life Sciences' Featuring Serina Therapeutics’ CEO - Wednesday, February ...
The new prefilled syringe simplifies the vaccine administration process as the existing vaccine consists of two vials that health care professionals must combine before administration. HealthDay News ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results